Medtronic Receives CE Mark Approval for SenSight(TM) Directional Lead System for DBS Therapy

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today annou... Devices, Neurology, Regulatory Medtronic, SenSight, Deep Brain Stimulation, neurostimulator
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news